It has been showing highly protective properties against several diseases such as cardiovascular dysfunctions [15], kidney diseases [16], hepatic dysfunctions [17], neuro cognitive disorders [18], diabetes [19], reproductive dysfunctions and infertility [20], skin diseases [21], cancer [22], digestion [23], retinal diseases [24] and other dysfunctions
Origin of post, Dr
10.3389/fendo.2021.721135 Summary Keywords lymphedema, GLP-1R agonists, GLP-1R agonist, GLP-1RAs, cancer-related lymphedema, Ozempic, semaglutide, liraglutide Citation Brown S, Tadros AB, Montagna G, Bell T, Crowley F, Gallagher EJ and Dayan JH (2024) Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
Choosing us means youre choosing a partner who is invested in your health beyond the short term